2016
$65M
from 11 investors over 11 rounds
Twentyeight-Seven Therapeutics raised $15M on May 9, 2019
Investors: Astellas Venture Capital L.L.C., Osage University Partners (OUP), MPM Capital, Longwood Fund, Sofinnova Partners and Vertex Ventures HC
Twentyeight-Seven Therapeutics raised $65M on September 6, 2018
Investors: Astellas Venture Capital L.L.C., Longwood Fund, MPM Capital and Vertex Ventures HC
Twentyeight-Seven Therapeutics raised undisclosed on April 5, 2016
Investors: MPM Capital